Gene: CPHXL2
Official Full Name: cytoplasmic polyadenylated homeobox like 2provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18572 | CPHXL2 Knockout cell line (HeLa) | Human | CPHXL2 | 1:3~1:6 | Negative | Online Inquiry |
KO18573 | CPHXL2 Knockout cell line (HCT 116) | Human | CPHXL2 | 1:2~1:4 | Negative | Online Inquiry |
KO18574 | CPHXL2 Knockout cell line (HEK293) | Human | CPHXL2 | 1:3~1:6 | Negative | Online Inquiry |
KO18575 | CPHXL2 Knockout cell line (A549) | Human | CPHXL2 | 1:3~1:4 | Negative | Online Inquiry |
CPHXL2 Gene Knockout Cell Lines are specialized cell lines engineered to lack the expression of the CPHXL2 gene, a critical component involved in cellular processes such as cell proliferation, differentiation, and apoptosis. These cell lines are produced using advanced gene-editing techniques, particularly CRISPR/Cas9 technology, which enables precise modifications at specific loci within the genome. By knocking out the CPHXL2 gene, researchers can effectively explore its role in various biological functions and disease models, offering insights into its impact on cellular pathways.
The primary mechanism of action involves the creation of a homozygous deletion of the CPHXL2 gene, leading to a loss of function that can be studied in various cellular contexts. By utilizing these knockout cell lines, scientists can assess how the absence of CPHXL2 influences signaling pathways related to cancer, metabolic disorders, and neurodegenerative diseases. This capability provides a powerful tool for elucidating gene function and exploring potential therapeutic targets in drug development.
The scientific importance of CPHXL2 Gene Knockout Cell Lines extends to both fundamental research and clinical applications. In research settings, they facilitate in-depth studies of gene interactions, help elucidate disease mechanisms, and pave the way for the identification of biomarkers. In clinical scenarios, understanding the role of CPHXL2 could lead to novel treatment strategies, particularly in areas where this gene is implicated in disease progression.
When compared to alternative models, our CPHXL2 Gene Knockout Cell Lines stand out for their reliability and reproducibility in research outcomes, as well as their compatibility with a wide range of assays. These cell lines are validated for consistent performance, ensuring that researchers can trust the data generated from their experiments.
For researchers and clinicians dedicated to advancing knowledge in genetics and disease mechanisms, the CPHXL2 Gene Knockout Cell Lines represent an invaluable resource that enhances experimental precision and enables groundbreaking discoveries. With our extensive experience in developing high-quality biological products, we provide not only these innovative cell lines but also comprehensive support for their optimal application in scientific research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.